Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets
Bayer AG
metastatic castrate resistant prostate cancer (mCRPC)
1 trial -
Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline
Disc Medicine
Carotid artery stenosis
1 trial -
Xolair 75 mg solution for injection in pre-filled syringe
Pari Pharma GmbH
Well controlled severe allergic asthma
1 trial -
Xtampza ER (oxycodone)
COLLEGIUM PHARMACEUTICAL, INC
Chronic Pain
1 trial -
Xtandi - 40 mg soft capsules
The George Institute
PROSTATE CANCER
1 trial -
Xuesaitong Soft Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
2 trials -
Xueshuanxinmaining tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Xyrem (X)
Jazz Pharmaceuticals Ireland Limited
Obstructive Sleep Apnea Syndrome
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
ZYNRELEF 200Mg-6Mg Extended-Release Solution
Heron Therapeutics
Post Operative Pain, Acute
1 trial -
Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione
Verona Pharma Ireland Limited
Patients with currently remitted depressive disorders.
1 trial -
Zeposia 0.92 mg hard capsules
Verona Pharma Ireland Limited
Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
1 trial -
Zhenyuan capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stable Coronary Heart Disease
1 trial -
Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZΒ 300Β mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg
Disc Medicine
HIV-infected
1 trial -
Zoledronate
United Therapeutics Europe Ltd
Hip Fractures
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
a control group
The First People's Hospital of Lianyungang
Disorder of Stomach Function and Feeding Problems in Newborn
1 trial -
alglucosidase alfa
Sanofi Pasteur
Pompe Disease (Infantile-Onset)
1 trial -
aripiprazole
Otsuka Beijing Research Institute
Bipolar Disorder
1 trial -
armodafinil
Teva Pharma GmbH
Sleep Disorders
1 trial -
aspirin 100mg/d therapy
The First People's Hospital of Lianyungang
Coronary Atherosclerosis
1 trial -
aspirin and clopidogrel
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
berberine hydrochloride
The First People's Hospital of Lianyungang
Hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources